NKTR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.59

Margin Of Safety %

Put/Call OI Ratio

0.79

EPS Next Q Diff

1.27

EPS Last/This Y

0.19

EPS This/Next Y

-3.02

Price

66.62

Target Price

153.25

Analyst Recom

1.2

Performance Q

-9.52

Upside

-264.3%

Beta

-0.82

Ticker: NKTR

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	NKTR	91.2	0.54	1.13	42037
2026-04-24	NKTR	91.58	0.57	2.48	42999
2026-04-27	NKTR	86.74	0.59	0.63	43690
2026-04-28	NKTR	84.61	0.60	0.54	44571
2026-04-29	NKTR	83.14	0.59	4.09	45951
2026-04-30	NKTR	85.03	0.62	0.10	46953
2026-05-01	NKTR	86.45	0.62	0.36	47281
2026-05-04	NKTR	86.83	0.62	0.74	47334
2026-05-05	NKTR	84.15	0.61	0.52	48238
2026-05-06	NKTR	84.96	0.60	0.14	48471
2026-05-07	NKTR	83.4	0.60	0.27	48511
2026-05-08	NKTR	81.74	0.61	0.34	48257
2026-05-11	NKTR	78.83	0.60	0.44	48398
2026-05-12	NKTR	78.42	0.61	2.55	48475
2026-05-13	NKTR	75.95	0.67	1.25	51059
2026-05-14	NKTR	74.67	0.65	1.35	50214
2026-05-15	NKTR	70.67	0.63	0.46	49913
2026-05-18	NKTR	68.53	0.84	0.57	28932
2026-05-19	NKTR	67.59	0.84	0.49	29776
2026-05-20	NKTR	69.49	0.84	0.60	30151
2026-05-21	NKTR	68.55	0.83	0.03	30473
2026-05-22	NKTR	66.59	0.79	0.23	30312
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	NKTR	91.19	55.6	-	-9.11
2026-04-24	NKTR	91.66	55.6	-	-9.11
2026-04-27	NKTR	86.78	55.6	-	-9.05
2026-04-28	NKTR	83.79	59.0	-	-8.54
2026-04-30	NKTR	85.04	59.0	-	-8.54
2026-05-01	NKTR	86.53	59.0	-	-8.54
2026-05-04	NKTR	86.86	59.0	-	-8.54
2026-05-05	NKTR	84.19	59.0	-	-8.54
2026-05-06	NKTR	84.96	59.0	-	-8.54
2026-05-07	NKTR	83.37	59.0	-	-8.54
2026-05-08	NKTR	81.74	59.0	-	-8.54
2026-05-11	NKTR	78.74	40.7	-	-8.71
2026-05-12	NKTR	78.47	25.1	-	-9.44
2026-05-13	NKTR	75.97	26.7	-	-9.44
2026-05-14	NKTR	74.34	26.7	-	-9.54
2026-05-15	NKTR	70.79	26.7	-	-9.54
2026-05-18	NKTR	68.48	26.7	-	-9.54
2026-05-19	NKTR	67.57	26.7	-	-9.54
2026-05-20	NKTR	69.49	26.7	-	-9.54
2026-05-21	NKTR	68.56	26.7	-	-9.54
2026-05-22	NKTR	66.62	26.7	-	-9.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	NKTR	-1.31	24.22	0
2026-04-24	NKTR	-1.31	24.22	12.62
2026-04-27	NKTR	-1.31	18.08	12.50
2026-04-28	NKTR	-1.31	18.08	12.50
2026-04-29	NKTR	-1.17	18.08	11.17
2026-04-30	NKTR	-1.17	18.08	11.17
2026-05-01	NKTR	-1.17	18.08	11.17
2026-05-04	NKTR	-1.17	18.70	11.17
2026-05-05	NKTR	-1.17	18.70	11.17
2026-05-06	NKTR	-1.17	18.70	11.17
2026-05-07	NKTR	-1.17	18.70	11.17
2026-05-08	NKTR	-1.17	18.70	11.17
2026-05-11	NKTR	-1.17	24.55	11.17
2026-05-12	NKTR	-1.17	24.55	12.62
2026-05-13	NKTR	-1.15	24.55	12.41
2026-05-14	NKTR	-1.15	24.55	12.41
2026-05-15	NKTR	-1.15	24.55	12.41
2026-05-18	NKTR	-1.15	23.15	12.37
2026-05-19	NKTR	-1.33	23.15	12.37
2026-05-20	NKTR	-1.33	23.15	12.37
2026-05-21	NKTR	-1.33	23.15	12.59
2026-05-22	NKTR	-0.76	23.15	12.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-1.78

Avg. EPS Est. Current Quarter

-2.04

Avg. EPS Est. Next Quarter

-0.52

Insider Transactions

-0.76

Institutional Transactions

23.15

Beta

-0.82

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

77.1

Max Drawdown 5-Year %

-97.8

Target Price

153.25

P/E

Forward P/E

PEG

P/S

40.45

P/B

2.36

P/Free Cash Flow

EPS

-8.42

Average EPS Est. Cur. Y

-9.54

EPS Next Y. (Est.)

-12.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-284.18

Relative Volume

0.52

Return on Equity vs Sector %

-54.5

Return on Equity vs Industry %

-38.9

EPS 1 7Days Diff

-1

EPS 1 30Days Diff

0.47

EBIT Estimation

◆ NKTR Healthcare

$66.61

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

15/25

Volume

11/15

Valuation

10/20

TP/AR

4/10

Options

5/10

RSI

Range 1M

6.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

12/30

Estimates

2/20

Inst/Vol

6/15

Options

6/10

EPS Yr

6.9%

EPS NY

-22.2%

52W%

58.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +130.1% upside

Quality

6/30

Valuation

16/30

Growth

6/25

Stability

7/10

LT Trend

0/5

Upside

+130.1%

Quality

Nektar Therapeutics

Sector: Healthcare

Industry: Biotechnology

Employees: 63

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.

NKTR

Latest News

—

Caricamento notizie per NKTR…

stock quote shares NKTR – Nektar Therapeutics Stock Price stock today

news today NKTR – Nektar Therapeutics stock forecast ,stock prediction 2023 2024 2025

marketwatch NKTR – Nektar Therapeutics yahoo finance google finance

stock history NKTR – Nektar Therapeutics invest stock market

stock prices NKTR premarket after hours

ticker NKTR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NKTR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y